Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

November 1, 2024 | COVID, Patient Retention, clinical trials, influenza, patient recruitment 

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs about patient and site considerations.

- PMLiVE

Don’t let all your recruitment efforts go down the drain—Retaining patients is key to a successful flu trial!

Discover fun and practical strategies to boost patient retention to keep your trial on track.

Dive into the final part of our ‘Is your influenza clinical trial prepared for the upcoming flu season?’ blog series!👉https://bit.ly/3XsEIiB

This content was provided by Innovative Trials

Company Details

- PMLiVE

Innovative Trials

Email
Website

 Latest Content from  Innovative Trials 

AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

Patient Recruitment in Oncology: A Phase III Melanoma Case Study

Boosting screening & enrollment rates in a global oncology trial

Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

Three Key Trends Shaping the Future of Clinical Trials

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

Innovative Trials names Hertfordshire hospice as 2025 UK charity partner

Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden House Hospice Care as its UK charity partner for 2025/26. It continues...

Education urgently needed to reverse lack of women-only clinical trials

Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.

Free Live Webinar – Patient Recruitment & Retention

Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!

Innovative Trials celebrates its 15th anniversary

🎉 Cheers to 15 years of patient recruitment and retention innovation and impact at Innovative Trials! 🎉 From 2010 to 2025, we’ve been on an incredible journey of growth, impact,...

Innovative Trials appoints first Non-Executive Chair

John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth